Crispr Therapeutics shares owned by T. Rowe Price Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by T. Rowe Price Investment Management
from 13F filings
Historical chart of T. Rowe Price Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by T. Rowe Price Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $213M | 3.3M | 64.81 |
| 2025-06-30 | $179M | 3.7M | 48.64 |
| 2024-12-31 | $150M | 3.8M | 39.36 |
| 2024-09-30 | $129M | 2.7M | 46.98 |
| 2024-06-30 | $148M | 2.7M | 54.01 |
| 2024-03-31 | $184M | 2.7M | 68.16 |
| 2023-09-30 | $166M | 3.7M | 45.39 |
| 2023-06-30 | $205M | 3.6M | 56.14 |
| 2023-03-31 | $166M | 3.7M | 45.23 |
| 2022-12-31 | $122M | 3.0M | 40.65 |
More positions owned by T. Rowe Price Investment Management
View all positions for T. Rowe Price Investment Management